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Abstract
Background: Tuberculosis (TB) is the most threatening infectious disease globally. Although progress has been
made to reduce global incidence of TB, emergence of multidrug resistant (MDR) TB threatens to undermine these
advances. To combat the disease, novel intervention strategies effective against drug resistant and sensitive
subpopulations of M. tuberculosis are urgently required as adducts in the present treatment regimen. Using THP-1
cells we have analyzed and compared the global protein expression profile of broth-cultured and
intraphagosomally grown drug resistant and sensitive M.tuberculosis clinical isolates.
Results: On comparing the two dimensional (2-DE) gels, many proteins were found to be upregulated/expressed
during intracellular state which were identified by matrix assisted laser desorption/ionization mass spectrometry
(MALDI-MS). Four proteins (adenosylhomocysteinase, aspartate carbomyltransferase, putatitive thiosulfate
sulfurtransferase and universal stress protein) were present in both intracellular MDR and sensitive isolates and
three of these belonged to intermediary metabolism and respiration category. Two proteins (alanine
dehydrogenase and adenosine kinase) of intracellular MDR isolate and two (glucose-6-phosphate isomerase and
ATP synthase epsilon chain) of intracellular sensitive isolate belonged to intermediary metabolism and respiration
category. One protein (Peroxidase/Catalase) of intracellular MDR and three (HSPX, 14 kDa antigen and 10 kDa
chaperonin) of sensitive isolate belonged to virulence, detoxification and adaptation category. ESAT-6 of
intracellular MDR belonged to cell wall and cell processes category. Two proteins (Antigen 85-C and Antigen 85-A)
of intracellular sensitive isolate were involved in lipid metabolism while probable peptidyl-prolyl cis-trans isomerase
A was involved in information pathways. Four (Rv0635, Rv1827, Rv0036c and Rv2032) of intracellular MDR and two
proteins (Rv2896c and Rv2558c) of sensitive isolate were hypothetical proteins which were functionally
characterized using bioinformatic tools. Bioinformatic findings revealed that the proteins encoded by Rv0036,
Rv2032c, Rv0635, Rv1827 and Rv2896c genes are involved in cellular metabolism and help in intracellular survival.
Conclusions: Mass spectrometry and bioinformatic analysis of both MDR and sensitive isolates of M. tuberculosis
during intraphagosomal growth showed that majority of commonly upregulated/expressed proteins belonged to
the cellular metabolism and respiration category. Inhibitors of the metabolic enzymes/intermediate can therefore
serve as suitable drug targets against drug-resistant and sensitive subpopulations of M. tuberculosis.
Background
Despite more than a century of research, tuberculosis
(TB) as a disease claims more deaths than any other
infectious agent making its causative organism Mycobac-
terium tuberculosis, one of the most successful human
pathogens. Inappropriate treatment regimens and
patient poor-compliance have led to the appearance of
drug resistant TB. Multi Drug Resistant TB (MDR-TB)
is caused by bacteria that are resistant to the most effec-
tive anti-TB drugs (Isoniazid and Rifampicin) with or
without resistance to other drugs. 50% of MDR-TB
c a s e si nw o r l da r ee s t i m a t e di nI n d i aa n dC h i n a[ 1 ] .I n
2010, the largest WHO MDR-TB survey reported the
highest rates of MDR-TB, with 28% of new TB cases in
some settings of the former Soviet Union [1]. This is an
alarming situation which calls for exploring therapeutics
equally effective against drug sensitive and resistant
population of M.tuberculosis.Am a j o ri m p e t u so fT B
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pounds capable to cure TB patients, regardless of
whether the disease is caused by M.tuberculosis which is
drug sensitive or resistant to the current first and sec-
ond line drugs [2]. Identification and development of
improved intervention strategies requires better under-
standing of host-pathogen interactions. Different
approaches have been used to study mycobacterial genes
that play a role in the interaction with host cells and
thus in virulence. These include in vivo- induced antigen
technology, subtractive hybridization, in vivo expression
technology etc. [3-5].
Proteomics is a powerful tool to study complex biologi-
cal samples and its application has greatly contributed to a
better understanding of the biology of M.tuberculosis and
other pathogenic bacteria. Putative drug targets, vaccine
candidates, and diagnostic markers for TB have also been
identified using this approach [6-8]. Identification of
mycobacterial proteins of drug resistant and sensitive iso-
lates by two-dimensional electrophoresis (2-DE) and mass
spectrometry has largely been applied to broth grown cul-
tures, because abundant amounts of protein are available
here for analysis and comparison. Such studies have been
carried out by us [9] and other researchers [10,11]. Diffi-
culty in recovery of sufficient amounts of protein from
intracellular state accounts for the existence of only a few
such studies [12,13]. To date, our knowledge regarding the
proteomic profiles of drug resistant and sensitive M.tuber-
culosis during intracellular growth have been fragmentary.
In the present work, we have analyzed the protein
expression profile of M.tuberculosis MDR and sensitive
isolates while infecting THP-1 cells to study the gene
expression changes that actually affect survival and
growth of resistant or sensitive isolates while growing
inside the host macrophage cells to identify proteins or
protein-class which are upregulated/expressed inside
macrophages and could be used as a common drug tar-
get for both types of microbial population.
Results
The goal of this study was to identify mycobacterial pro-
teins upregulated/expressed during growth in macro-
phages by comparative proteome analysis of broth-
cultured and intraphagosomally grown mycobacteria. To
elucidate protein spots unique to intraphagosomal
mycobacteria the generated 2-DE gels (Figure 1) were
analyzed using the software program PDQuest (Biorad,
USA) and spots which were upregulated/expressed with
at least 2.5 intensity were selected.
2-DE of intracellular M.tuberculosis MDR isolate proteins
and their MALDI-MS analysis
Comparison of composite 2-DE gels of broth-cultured
M. tuberculosis MDR and sensitive isolates with
intraphagosomally grown M.tuberculosis MDR isolate
showed sixteen protein spots to be upregulated/
expressed by the intraphagosomal mycobacteria (Figure
1B). Spots I1 and I2 (Rv1908c) were identified as peroxi-
dase/catalase. Spots I3, I4, I5, I6 (Rv3248c) were identi-
fied as isoforms of Adenosylhomocysteinase. I7 (Rv2623)
was identified as a Universal stress protein. Spots I8
(Rv2780c) and I9 (Rv2202c) were identified as Alanine
dehydrogenase and Adenosine kinase respectively. Spots
I10 (Rv2032), I13 (Rv0036c), I14 (Rv1827) and I15
(Rv0635) were identified as hypothetical proteins. Spot
I12 (Rv1380) was identified as Aspartate carbamoyl-
transferase. Spot I11 (Rv0815c) was identified as Puta-
tive thiosulfate sulfurtransferase. Spot I16 (Rv2347c) was
identified as a putative ESAT-6 like protein. Table 1
shows details of upregulated/expressed proteins identi-
fied by mass spectrometry.
2-DE of intracellular M.tuberculosis drug sensitive isolate
proteins and their MALDI-MS analysis
Comparison of composite 2-DE gels of broth-cultured
M. tuberculosis MDR and sensitive isolates with intra-
phagosomally grown M.tuberculosis sensitive isolate
showed twenty one protein spots which were upregu-
lated/expressed by the intraphagosomal mycobacteria
(Figure 1C). Spot D1 (Rv0946c) was identified as Glu-
cose-6-phosphate isomerase. Spots D2, D3, D4, D5, D6,
(Rv3248c) were identified as isoforms of Adenosylhomo-
cysteinase. Spots D7 (Rv2896c) and D13 (Rv2558) were
identified as a hypothetical proteins. D8 (Rv2623) was
identified as a Universal stress protein. Spots D9
(Rv0129c) and D12 (Rv3804c) were identified as Antigen
85-C and Antigen 85-A mycolyl transferases. Spot D10
(Rv1380) was identified as Aspartate carbamoyltransfer-
ase. Spot D11 (Rv0815c) was identified as Putative thio-
sulfate sulfurtransferase. Spots D14 and D15 were
Probable peptidyl-prolyl cis-trans isomerase A (Rv0009).
Spots D16 and D17 (Rv1311) were identified as ATP
synthase epsilon chain. Spots D18, D20 (Rv2031c) and
D19 (Rv0251) were identified as 14 kDa antigen, heat
shock protein HSPX. Spot D21 (Rv3418c) was 10 kDa
chaperonin. Table 2 shows details of differentially
expressed proteins identified by mass spectrometry.
Functional characterization of hypothetical proteins
employing bionformatic tools
(a) BLAST Analysis
Prediction of probable function of hypothetical proteins
was done using BLASTp search performed at NCBI ser-
ver http://blast.ncbi.nlm.nih. The top five BLAST hits of
all six mycobacterial proteins showed statistically signifi-
cant alignment with 90-100% sequence coverage.
Rv0036, Rv2032c, Rv2896c and Rv2558 though found to
be highly conserved in mycobacterial species could not
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as hypothetical proteins. BLAST hits of Rv0635 were
found to be highly conserved in different mycobacterial
species where it functions like 3R-hydroxyacyl-ACP
dehydratase subunit HadA. BLAST hits of Rv1827 were
highly conserved in mycobacterial sp. but attributed it
diverse functional annotations like hypothetical protein
sequences, Chain A Pknb-Phosphorylated protein, FHA
(Forkhead-associated) domain containing protein. FHA
domain is a phosphopeptide recognition domain found
in many regulatory proteins. As BLAST analysis could
not reveal probable function of many proteins, we also
searched for the presence of motif in these proteins
using MotifScan.
(b) MotifScan Analysis
MotifScan run was performed for all the hypothetical
proteins, but no motif was found except in Rv0635. A
motif YNNN_MF_00799 http://myhits.isb-sib.ch/cgibin/
view_mot_entry?name=hamap:YNNN_MF_00799 was
detected in Rv0635. This motif is conserved in UPF0336
family of proteins. The proteins of this family comprise
M. leprae, M. paratuberculosis, M. tuberculosis and M.
bovis in addition to many other species of bacteria. This
motif is termed as MaoC_dehydratas domain which is a
member of HotDog superfamily and is involved in oxi-
doreductase activity.
(c) Domain Analysis
We selected top five BLAST hits for probing into the
conserved domains and hence annotating the function
of each query protein http://www.ncbi.nlm.nih.gov/cdd.
Rv0635 had a putative R_hydratase like conserved
domain http://www.ncbi.nlm.nih.gov/Structure/cdd/
cddsrv.cgi?uid=4803 which is found in the proteins
belonging to HotDog superfamily. Analysis of conserved
Figure 1 Coomassie stained composite 2-DE gels of M. tuberculosis clinical isolates, cell lysate proteins run on 17 cm IPG strip of pH
4-7 and SDS-PAGE was performed on 22 cm × 20 cm gel. (A) broth-cultured M.tuberculosis MDR and sensitive clinical isolates (B)
intraphagosomally grown M.tuberculosis MDR clinical isolate and (C) intraphagosomally grown M.tuberculosis drug sensitive clinical isolate.
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Spot No. Protein identified MASCOT Score Nominal Mass (Da) pI Sequence Coverage % Accession Number
I1 Peroxidase/catalase T 144 80725 5.09 31% Rv 1908c
I2 Peroxidase/catalase T 64 80725 5.09 9% Rv 1908c
I3 Adenosylhomocysteinase (AdoHcyase) 105 54461 5.07 23% Rv 3248c
I4 Adenosylhomocysteinase (AdoHcyase) 120 54461 5.07 25% Rv 3248c
I5 Adenosylhomocysteinase (AdoHcyase) 88 54461 5.07 19% Rv 3248c
I6 Adenosylhomocysteinase (AdoHcyase) 80 54461 5.07 17% Rv 3248c
I7 Universal stress protein 162 31747 5.46 57% Rv2623
I8 Alanine dehydrogenase 90 38974 5.81 31% Rv2780c
I9 Adenosine kinase 108 34621 5.14 31% Rv2202c
I10 Hypothetical protein 82 36765 5.28 23% Rv2032
I11 Putative thiosulfate sulfurtransferase 37 31110 5.14 24% Rv0815c
I12 Aspartate carbamoyltransferase (ATCase) 50 33798 6.60 22% Rv1380
I13 Hypothetical protein 95 27586 4.84 44% Rv0036c
I14 Hypothetical protein 64 17240 4.29 34% Rv1827
I15 Hypothetical protein 85 17584 4.51 51% Rv0635
I16 Putative ESAT-6 like protein 57 10970 5.17 29% Rv2347c
Table 2 Details of over-expressed proteins of M.tuberculosis drug sensitive isolate identified by mass spectrometry
Spot
No.
Protein identified MASCOT
Score
Nominal Mass
(Da)
pI Sequence
Coverage %
Accession
Number
D1 Glucose-6-phosphate isomerase (GPI) 136 59937 5.40 29% Rv0946c
D2 Adenosylhomocysteinase (AdoHcyase) 87 54461 5.07 19% Rv 3248c
D3 Adenosylhomocysteinase (AdoHcyase) 177 54461 5.07 38% Rv 3248c
D4 Adenosylhomocysteinase (AdoHcyase) 188 54461 5.07 41% Rv 3248c
D5 Adenosylhomocysteinase (AdoHcyase) 58 54461 5.07 13% Rv 3248c
D6 Adenosylhomocysteinase (AdoHcyase) 60 54461 5.07 11% Rv 3248c
D7 Hypothetical protein 20 40376 6.61 12% Rv2896c
D8 Universal stress protein 113 31747 5.46 57% Rv2623
D9 Antigen 85-C, Mycolyl Transferase 85c 85 36771 5.1 30% Rv0129c
D10 Aspartate carbamoyltransferase (ATCase) 60 33798 6.60 24% Rv1380
D11 Putative thiosulfate sulfurtransferase 37 31110 5.14 24% Rv0815c
D12 Antigen 85-A FBPA (Mycolyl transferase 85A) 80 28634 5.3 25% Rv3804c
D13 Hypothetical protein 21 26044 6.18 6% Rv2558
D14 Probable peptidyl-prolyl cis-trans isomerase A 30 19285 5.80 20% Rv0009
D15 Probable peptidyl-prolyl cis-trans isomerase A 110 19285 5.80 54% Rv0009
D16 ATP synthase epsilon chain ATPC 51 13127 4.55 25% Rv1311
D17 ATP synthase epsilon chain. 38 13127 4.55 26% Rv1311
D18 Heat shock protein HSPX (alpha-crystallin homolog) (14 kda
antigen) HSP16.3
108 16217 5.0 59% Rv2031c
D19 14 kDa antigen (16 kDa antigen) 74 16217 5.00 38% Rv0251c
D20 Heat shock protein HSPX (alpha-crystallin homolog) (14 kda
antigen) HSP16. 3.
79 16217 5.0 37% Rv2031c
D21 10 kDa chaperonin 67 10798 4.62 35% Rv3418c
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of FHA http://www.ncbi.nlm.nih.gov/Structure/cdd/
cddsrv.cgi?uid=28942 and a phospopeptide binding site
and analysis of Rv0036 revealed presence of two con-
served domains, of MDMPI_N Superfamily and Radical_
SAM superfamily http://www.ncbi.nlm.nih.gov/Struc-
ture/cdd/cddsrv.cgi?uid=175426. In the top five BLAST
hits of Rv2032c we found a conserved domain belonging
to Nitro_FMN_reductase superfamily and a site which
forms a dimer interface http://www.ncbi.nlm.nih.gov/
Structure/cdd/cddsrv.cgi?uid=174256. A Lysine_decar-
box conserved domain was found to be present in the
top five BLAST hits of Rv2896c http://www.ncbi.nlm.
nih.gov/Structure/cdd/wrpsb.cgi?RID=7FEA98PB016
while no conserved domains were found to be present
in the top five BLAST hits of Rv2558.
Discussion
I nt h ep r e s e n ts t u d yw eh a v ea n a l y z e dt h ep r o t e i np r o -
files of M.tuberculosis MDR and sensitive clinical iso-
lates while infecting human macrophage-like THP-1
cells as a means of analyzing the environmental condi-
tions faced by the pathogen during infection. This may
contribute significantly in understanding whether
mechanisms adopted by resistant and sensitive myco-
bacteria to survive and grow inside the host macro-
phages are similar or different and would help in finding
new drug targets. The use of human THP-1 macrophage
cell line, rather than human peripheral blood monocyte
derived or alveolar macrophages, was necessary to pro-
vide sufficient cells to recover intracellular mycobacteria.
MALDI-MS identification of the intracellular MDR
and sensitive isolates revealed that majority of the com-
mon proteins upregulated/expressed in the intracellular
state belonged to intermediary metabolism and respira-
tion category. Four proteins (adenosylhomocysteinase,
aspartate carbomyltransferase, putatitive thiosulfate sul-
furtransferase and universal stress protein) were present
in both isolates and three of these belonged to inter-
mediary metabolism and respiration category. Two pro-
teins (alanine dehydrogenase and adenosine kinase) of
intracellular MDR isolate and two (glucose-6-phosphate
isomerase and ATP synthase epsilon chain) of intracel-
lular sensitive isolate belonged to intermediary metabo-
lism and respiration category. One protein (Peroxidase/
Catalase) of intracellular MDR and three (HSPX, 14kDa
antigen and 10kDa chaperonin) of sensitive isolate
belonged to virulence, detoxification and adaptation
category. ESAT-6 of intracellular MDR belonged to cell
wall and cell processes category. Two proteins (Antigen
85-C and Antigen 85-A) of intracellular sensitive isolate
were involved in lipid metabolism while probable pepti-
dyl-prolyl cis-trans isomerase A was involved in infor-
mation pathways. Four (Rv0635, Rv1827, Rv0036c and
Rv2032) of intracellular MDR and two proteins
(Rv2896c and Rv2558c) of sensitive isolate were
hypothetical proteins which were functionally character-
ized using bioinformatic tools.
Adenosylhomocysteinase (SAHH) catalyzes the rever-
sible hydrolysis of S-adenosylhomocysteine (SAH) into
free adenosine (ADO) and L-homocysteine (HCY). SAH
is produced from S-adenosylmethionine (SAM) as a by-
product of SAM-dependent methyltransferase reactions.
Methylation plays a role in a wide range of cellular pro-
cesses, including DNA replication and repair, methio-
nine metabolism, polyamine and phospholipid
biosynthesis. SAHH is also considered “druggable” [14],
has been shown to be essential for growth in vitro and
appears to be upregulated in infected mouse lung tissue
[15]. Aspartate carbamoyltransferase (also known as
aspartate transcarbamoylase or ATCase) catalyzes the
first step in the pyrimidine biosynthetic pathway. Thio-
sulfate sulfurtransferase is a Rhodanese-like protein
which catalyzes transfer of sulfane sulfur from substrate
to enzyme active site and then to a thiophilic acceptor.
Much information on the functional role of rhodanese
is not available however lack of rhodanase encoding
gene has shown to affect the sensitivity of Azotobacter
vinelandii to oxidative damages [16]. M. tuberculosis has
universal stress proteins, whose function is unknown.
Proteomic and transcriptomic analysis have shown that
a number of these genes are significantly upregulated
under hypoxic conditions and in response to nitric
oxide and carbon monoxide, as well as during M. tuber-
culosis infection of macrophage cell lines, suggesting
their probable role in persistence and/or intracellular
survival [17].
NAD (H)-dependent L-alanine dehydrogenase cata-
lyzes the oxidative deamination of L-alanine and reduc-
tive amination of pyruvate to generate alanine for
protein and peptidoglycan synthesis and plays a key role
in cell wall synthesis. Feng et al. [18] have shown its
important role in alanine utilization and anaerobic
growth in mycobacteria. Huttera and Dicka [19] using
M.smegmatis reported its upregulated during oxygen
depletion-induced dormancy. This indicates that during
intracellular state bacilli are not metabolically inactive
but maintain a low level metabolism to tide over the
unfavorable condition. Adenosine kinase which catalyzes
the phosphorylation of adenosine is important for the
regulation of cellular levels of adenosine and its nucleo-
tides and was found to be expressed by MDR isolate
during intracellular state. Purine metabolism has been
proposed as a drug target [20]. Glucose-6-phosphate iso-
merase (PGI) plays a central role in glycolysis and glu-
coneogenesis. Interruption of PGI gene resulted in
glucose auxotrophy [21]. During mycobacterium infec-
tion in macrophages, a metabolic shift from a strict
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occurs, with a significant increase in the levels of glyco-
lytic enzymes. During this stage, 70% of the organism’s
energy is derived from glycolysis. Thus, being central to
the organism’s survival, the enzymes involved in glycoly-
sis are an attractive target for drug design. M.tuberculo-
sis sensitive isolate showed an increased expression of
ATP synthase epsilon chain. ATP synthase epsilon chain
produces ATP in presence of a proton gradient across
the membrane. Tran and Cook [22] showed that it is an
essential gene in M. smegmatis during growth on non-
fermentable and fermentable carbon sources. Gengenba-
cher et al. [23] showed that nutrient-starved, non-
replicating M.tuberculosis requires respiration, ATP
synthase and isocitrate lyase for maintenance of ATP
homeostasis and viability.
Intracellular MDR isolate showed an increased expres-
sion of Catalase/peroxidase protein. Encoded by the
katG gene it is an important virulence determinant of
M.tuberculosis which protects against oxidative stress.
Catalse/peroxidase activity has been shown necessary for
growth and persistence in mice and guinea pigs [24]
and in human peripheral blood monocyte [25]. Isonia-
zid, a widely used frontline antimycobacterial agent
requires activation by catalase-peroxidase KatG before
exerting a lethal effect. KatG couples the isonicotinic
acyl with NADH to form isonicotinic acyl-NADH com-
plex that ultimately confers antitubercular activity [26].
HSPX is a 14kDa antigenic stress protein induced by
anoxia and has a proposed role in maintenance of long-
term viability during latent, asymptomatic infections, in
replication during initial infection of macrophages
[12,27].
6 kDa early secreted antigenic targets (ESAT-6) which
forms a heterodimeric complex with culture filtrate pro-
tein (CFP-10) was exclusively detected during intracellu-
lar growth of MDR isolate and is involved in host-
pathogen interactions. They induce a strong T cell
mediated response, involved in membrane/host-cell lysis
and represent key virulence factors [28]. ELISA-IGRA
test uses ESAT-6 and CFP-10 as stimulating antigens
for detecting tuberculosis infection [29] and has the
ability to discriminate between tuberculosis infection
and previous use of BCG vaccine or atypical mycobac-
teria reactivity.
Antigen 85-C and Antigen 85-A mycolyl transferases
constitute a major fraction of the secreted proteins of
M. tuberculosis culture filtrate. Gene disruption studies
encoding the three Ag85 components of M. tuberculosis
suggests that Ag85A may be the most essential compo-
nent for bacterial survival within macrophages. Ag85A
and Ag85B have been reported to be ideal vaccine can-
didates in a number of studies [30,31]. Peptidyl-prolyl
cis-trans isomerases catalyzes the interconversion of cis
and trans peptide bonds and are therefore considered to
be important for protein folding. They are also thought
to participate in processes such as signalling, cell surface
recognition, chaperoning and heat shock response [32].
14 kDa antigen (16 kDa antigen) is believed to be
involved in the initiation step of translation at high tem-
perature and is possibly a molecular chaperone. Sharma
et al. found that the expression of this protein was upre-
gulated in drug -pressure of streptomycin [33]. Chapero-
nins form a sub-group of molecular chaperones and 10-
kDa antigen has homology with the GroES or chapero-
nin-10 (Cpn 10) family of heat shock proteins [34]. 10-
kDa antigen has been shown to be an important T-cell
antigen in tuberculosis patients.
Further, intracellular resistant/sensitive M.tuberculosis
hypothetical proteins were functionally characterized
using bioinformatics tools. Rv0036, Rv2032c, Rv2896c
and Rv2558 though found to be highly conserved in
Mycobacterium species could not be assigned any func-
tion through BLASTp analysis. Motif Scan webserver
also didn’t find any motifs in these proteins while CDD
found conserved domains in these except Rv2558. Top
five BLAST hits of Rv0036 revealed the presence of two
conserved domains, MDMPI_N and Radical_ SAM
superfamily. No information is available on the function
of proteins belonging to MDMPI_N Superfamily. As
enzymes of Radical SAM superfamily catalyze steps in
metabolism, DNA repair etc. [35], it can be inferred that
Rv0036 may participate in such activities. Rv2032c
showed a conserved domain belonging to Nitro_FMN_-
reductase superfamily. Proteins of this superfamily cata-
lyze the reduction of flavin or nitrocompounds.
Lysine_decarbox conserved domain was found in
Rv2896c. This family includes proteins annotated as
lysine decarboxylases, whose synthesis is enhanced on
exposure to fluoroquinolones [36]. Rv0635 was found
highly conserved in different Mycobacterium species
where it functions like 3R-hydroxyacyl-ACP dehydratase
subunit HadA. MotifScan analysis predicted the pre-
sence of YNNN_MF_00799 motif which is conserved in
UPF0336 family of proteins. This motif is termed as
MaoC_dehydratase domain which is a member of Hot-
Dog superfamily and is involved in oxidoreductase activ-
ity. CDD investigation also revealed the presence of
R_hydratase like conserved domain in Rv0635. Dhillon
and Bateman [37] unified numerous prokaryotic,
archaeal and eukaryotic proteins and found that hotdog
domain containing proteins wrap up a superfamily of
thioesterases and dehydratases. Combining the results of
BLASTp, MotifScan and CDD it can be inferred that
Rv0635 codes for a metabolic enzyme which may be
involved in dehydratase activities. BLAST hits of Rv1827
f o u n di tt ob eh i g h l yc o n s e r v e di nMycobacterium spe-
cies but attributed diverse functional annotations to it
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Phosphorylated protein, FHA (Forkhead-associated)
domain containing protein. MotifScan reported no
motifs in Rv1827 while CDD analysis revealed the pre-
sence of FHA domain. It is a putative nuclear signalling
domain and is known to mediate phosphorylation-
dependent protein-protein interactions. Diverse func-
tional attributes associated with FHA-domain containing
proteins like cell shape regulation, signal transduction,
ethambutol resistance etc. [38] and the expression of
Rv1827 by MDR isolate during intraphagosomal state
highlights the importance of this protein in cellular phy-
siology of bacteria and its intracellular survival. Based
on the bioinformatics findings we can predict that pro-
teins encoded by Rv0036, Rv2032c, Rv0635, Rv1827 and
Rv2896c genes are involved in cellular metabolism and
help in intracellular survival of drug resistant/sensitive
M.tuberculosis.
Conclusions
Taken together, the identified proteins unique to intra-
phagosomal M.tuberculosis are likely to contribute to
the adaptation of the bacteria to the milieu within pha-
gosomes. The deduced functions of identified proteins
are consistent with the conditions encountered within
the macrophages. The induction of their expression
observed in vitro may therefore represent a strategy
employed by M.tuberculosis to promote the infection
and to enhance intracellular survival. Identification of
the exact role of these proteins will allow direct interfer-
ence with their function to control intracellular growth
of mycobacteria.
Mass spectrometry and bioinformatic characterization
of both drug resistant and sensitive isolates of M.tuber-
culosis during intraphagosomal growth showed that
majority of commonly expressed/upregulated proteins
belonged to the cellular metabolism and respiration
category. Though both the clinical isolates were from
different clades, some proteins common in them were
found overexpressed. It represents that some common
mechanisms is adopted by sensitive/resistant mycobac-
teria for their survival within macrophages and thus
could serve as important drug targets. The substantive
response of the host immune system that includes both
oxidative and nitrosative stress provokes M.tuberculosis
to adopt metabolic enzymes to catabolize these toxic
compounds and undergo fundamental physiological and
metabolic changes to facilitate intracellular survival.
Matteelli et al. [39] reported that TMC207 is a first-in-
class anti-TB diarylquinoline with activity against drug-
sensitive and resistant TB and appears to be safe and
well tolerated. It inhibits the proton pump of mycobac-
terial ATP synthase, a critical enzyme in the synthesis of
ATP for M. tuberculosis. Though knowledge is meagre
regarding the metabolism M. tuberculosis during its resi-
dence in host cells but studies have shown that M.
tuberculosis faces a hypoxic, carbon-poor, oxidative, and
nitrosative environment in the host cells and organs. A
close intersection exists between core intermediary
metabolism and resistance to host-imposed biochemical
stress in M. tuberculosis which has suitably adapted its
metabolism for persistence in the human macrophage.
Inhibitors of the metabolic enzymes therefore warrant
exploration as suitable drug targets against drug-resis-
tant and sensitive subpopulations of M.tuberculosis.
Methods
Source of culture
M.tuberculosis drug sensitive (to five first line drugs)
(ST11/EAI3_IND family) and MDR (resistant to rifampi-
cin, isoniazid and streptomycin) (ST288/CAS2 family)
clinical isolates were procured from Mycobacterial
Repository Center at National JALMA Institute for
Leprosy and other Mycobacterial Diseases, Agra. Sus-
ceptibility testing was performed by conventional LJ
proportion method [40]. Cultures were grown in Sau-
ton’s liquid medium at 37°C and harvested in late expo-
nential phase (3 weeks) of growth [41,42]. These
cultures were used for macrophage infection.
Culture of cell line and infection with mycobacteria
The human leukemic macrophage like cell line THP-1
(kind gift from National Centre for Cell Science, Pune,
India) was routinely maintained as suspended cells in
RPMI 1640 media (Sigma, USA), supplemented with
10% v/v heat-inactivated foetal calf serum, 2 mM gluta-
mine and 100 μg/ml antibiotic-antimycotic cocktail
from Sigma (penicillin, streptomycin, amphotericin B) at
37°C in a CO2 humidified incubator. Cells were grown
to a density of 2-5 × 10
6 cells/ml in 25 cm
2 flat-bottom
tissue culture flasks and passaged every third day. Prior
to infection with M.tuberculosis isolates the THP-1 cells
were passaged at least three times in supplemented anti-
biotic-free RPMI 1640 growth medium before expansion
into 75 cm
2 flat bottom tissue culture flasks containing
30 ml RPMI 1640 growth medium. The cells grown to a
density of 2-5 × 10
6/ml, were stimulated with 20 nM
(12 ng/ml) phorbol 12-myristate13 acetate (PMA;
Sigma-Aldrich, USA) for 24 hours so as to allow the
cells to adhere [12]. Non-adherent cells were removed
by washing twice in warm RPMI 1640 (at 37°C) and the
resulting monolayers (approx.3-5 × 10
7cells per flask)
were covered with 30 ml supplemented RPMI 1640
growth medium. Mid-exponential phase mycobacterial
cells (5 × 10
8 bacilli) recovered from Sauton’sl i q u i d
medium by centrifugation at 5000 g for 10 minutes
were resuspended in 1 ml RPMI 1640 growth medium
and added to the adhered macrophage monolayer at an
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to phagocytose for 12 hours (to ensure that sufficient
mycobacteria are taken up by macrophages) at 37°C in a
5% humidified CO2 incubator. After 12 hours extracellu-
lar mycobacteria were removed by decanting the super-
natant and extensively washing the adhered cells twice
in warm RPMI 1640. The infected macrophages were
replenished with 30 ml complete RPMI 1640 medium
containing gentamycin (10 μg/ml) to prevent extracellu-
lar replication of mycobacteria. Macrophage viability
(never fell below 80%) was assessed by trypan blue
exclusion. Incubations were carried out for further 5
days at 37°C in a humidified CO2 incubator. After 5
days incubation, the supernatant was discarded and
macrophages were washed and scrapped off in chilled
Phosphate buffered saline (PBS) solution. The macro-
phages were then lysed by incubating for 5 minutes at
37°C in 0.05% SDS/PBS (w/v). Lysed cell suspension was
transferred to 15 ml centrifuge tubes and centrifuged at
5000 g for 20 minutes. To remove any contaminating
macrophage proteins, and ensure the recovery of intra-
cellular mycobacteria only, pelleted mycobacteria were
pooled and washed further two times in PBS containing
0.1% Tween 80 (w/v) and 0.1% (w/v) SDS. The washed
mycobacterial pellet containing only the intracellular
mycobacteria was finally collected.
Mycobacterial cell lysate proteins
Cell lysate proteins were prepared according to the
recommended protocol [44] with slight modification.
Intracellular mycobacterial pellet was suspended (0.2 g/
ml) in lysis buffer (50 mM Tris/HCl, pH 7.4 with 10
mM MgCl2, 1 mM PMSF and 1 mM EGTA) and soni-
cated for 15 minutes intermittently. Lysates were clari-
fied by centrifugation at 10, 000 g for 30 minutes. Using
similar protocol cell lysate proteins of broth- grown
mycobacterial cells was also prepared. Liquid cultures of
MDR and sensitive isolates grown in Sauton’sl i q u i d
medium were harvested in mid exponential phase of
growth. Cells were collected, washed in PBS and lysate
proteins prepared.
Protein precipitation with SDS-TCA-acetone
Cell lysate was treated with 1% SDS and then subjected
to trichloro acetic acid (TCA)-acetone precipitation pro-
cedure [45]. 10% TCA was added to the cell lysate, the
mixture was incubated at -20°C overnight and then pre-
cipitated protein was collected by centrifugation at 18,
000 g at 4°C for 15 minutes. It was again washed twice
with 100% ice cold acetone and allowed to air dry. The
protein pellet was suspended in appropriate volume of
two-dimensional rehydration buffer (BIO-RAD, Her-
cules, CA, USA). Protein concentration was estimated
using the Bradford assay [46].
Two-dimensional gel electrophoresis (2-DE)
Isoelectric focusing (IEF) was carried out using the
method of ‘in gel rehydration’ [47] with slight modifica-
tions. Immobilized pH gradient (IPG) strips of pH 4-7
and length 17 cm (BIO-RAD, Hercules, CA, USA) were
rehydrated overnight at 20°C with 500 μgp r o t e i nm i x e d
with rehydration buffer. Strips were then focused on an
IEF unit PROTEAN IEF Cell (BIO-RAD, Hercules, CA,
USA) using the following four step programme: a) 0-250
V for 2 hours in linear mode; b) 250 V constant for 2
hours in rapid mode; c) 250-5000 V for 4 hours in linear
mode; and d) 5000 V constant until 35 kVh reached. The
current limit was set at 50 μA per strip. After IEF, IPG
strips were equilibrated for 15 minutes in equilibration
buffer I (6 M urea, 2% SDS, 0.375 M Tris; pH 8.8, 20%
glycerol) containing 130 mM dithiothreitol (DTT) fol-
lowed by equilibration buffer II containing 135 mM
iodoacetamide instead of DTT for 15 minutes. Proteins
were separated in second dimension on 12% SDS-PAGE
[48] in a vertical electrophoretic dual gel unit PROTEAN
II XI (BIO-RAD, Hercules, CA, USA) at constant voltage
of 250 V for 5-6 hours. Gels were stained with Coomassie
Brilliant Blue R250 to visualize proteins. Images of gels
were acquired by Chemidoc (BIO-RAD) using Quantity
O n es o f t w a r e( B I O - R A D ,H e r c u l e s ,C A ,U S A ) .2Dg e l s
were analysed using PDQuest Advanced software (BIO-
RAD, Hercules, CA, USA). Gel images were also manu-
ally checked for artifactual spots, merged spots, and
missed spots. Equal amount of protein was loaded in all
gels and experiments were repeated at least three times.
In-gel digestion with trypsin
Method of Shevchenko et al. [49] was followed with
slight modifications. Protein spots of interest were
excised from gels using spot picker ‘Investigator ProPic’
(Genomic Solutions, Huntingdon, UK) and collected in
96 well PCR plate. Digestion of proteins and spotting of
peptides on MALDI-TOF target plate was carried out
using protein digester ‘Investigator ProPrep’ (Genomic
Solutions, Huntingdon, UK). The gel plugs were
destained and dehydrated by washing three times (~10
minutes) with 25 mM NH4HCO3-50% acetonitrile
(ACN) (1:1). Dried gel plugs were treated with freshly
prepared 10 mM DTT in 50 mM NH4HCO3 for 45
minutes at 56°C. After incubation, the DTT was
replaced quickly by the same volume of freshly prepared
55 mM iodoacetamide in 50 mM NH4HCO3 for 30
minutes and then dehydrated with 100% ACN. The
dried gel pieces were incubated for 12 hours at 37°C
with 25 mM NH4HCO3 containing 0.02 μg/μlo fm a s s
spectrometry grade trypsin (Promega, Madison, WI,
USA). The resulting peptides were extracted twice from
the gel pieces, using peptide extraction buffer [1:1 mix-
ture of 70% ACN and 0.1% trifluoroaceticacid (TFA)].
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Digested samples were desalted and concentrated on C-
18 ZipTips (Millipore, Billerica, MA, USA) using the
manufacturer’s protocol. ZipTips were eluted on MTP
384 target plate with 2 μl of a-cyano-4-hydroxycinnami-
cacid (HCCA) (Sigma-Aldrich, USA) saturated solution
dissolved in 50% ACN and 0.2% TFA. Mass spectra of
digested proteins were acquired using Autoflex II TOF/
TOF 50 (Bruker Daltonik GmbH, Leipzig, Germany) in
positive reflectron mode, in the detection range of 500-
3000 m/z. External calibration to a spectrum, acquired
for a mixture of peptides with masses ranging from
1046 to 2465 Da, was done prior to acquisition. The
proteolytic masses obtained were then processed
through Flex Analysis v.2.4 programme for peak detec-
tion of proteins. Peak detection in MALDI spectra and
submission of peak lists to the Peptide mass fingerprint
(PMF) Mascot server were done using the Mascot
Wizard program (Matrix Science, U.K). Peptide mass
tolerance was set to 50 ppm with carbamidomethyl-
cystein set as fixed modification, oxidation of methio-
nine as variable modification and 1 missed cleavage site
was allowed.
Computational analysis of hypothetical proteins
employing bioinformatics tools
Computational analysis of the differentially expressed
hypothetical proteins was carried out using softwares
and web-servers like BLASTp, MotifScan and Conserved
Domain Database (CDD). Protein sequences of all
hypothetical proteins were retrieved from Tuberculist
server http://genolist.pasteur.fr/TubercuList/ hosted by
Pasteur Institute, Paris for whole annotated genome of
H37Rv.
(a) BLAST Analysis
The prediction of probable function of hypothetical pro-
teins was done using BLASTp search [50] performed at
NCBI server http://blast.ncbi.nlm.nih. Protein sequence
of hypothetical proteins was retrieved from Tuberculist
server http://genolist.pasteur.fr/TubercuList. Top five
BLAST hits were selected for annotating the function.
BLAST runs were performed at NCBI server using the
default threshold E-value of 10 and inclusion of thresh-
old value of 0.005.
(b) Motif Scan Analysis
The motif search was done using HAMAP profiles and
PROSITE patterns motif databases [51].
(c) Domain Analysis
The Conserved Domain Database (CDD) of NCBI which
is a database of multiple sequence alignment [52] was
used to predict functions of hypothetical proteins. Top
five BLAST hits were selected for probing into the con-
served domains and functional annotation http://www.
ncbi.nlm.nih.gov/cdd.
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